Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

91
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
91
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

45
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
45
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Intellectual Disability01:29

Intellectual Disability

35
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
35
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development.

Neurology·2024
Same author

Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.

Neurology. Clinical practice·2024
Same author

Artificial intelligence and technology collaboratories: Empowering innovation in AI + AgeTech.

Journal of the American Geriatrics Society·2024
Same author

Caregiver Accounts of Lucid Episodes in Persons With Advanced Dementia.

The Gerontologist·2023
Same author

Gender of Study Partners and Research Participants Associated With Differences in Study Partner Ratings of Cognition and Activity Level.

The journals of gerontology. Series B, Psychological sciences and social sciences·2023
Same author

Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.

Neurology·2023
Same journal

Neural Organoids: How Should We Handle the Possibility of Sentience? - CORRIGENDUM.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

Sentience. Not Necessarily a Problem?

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

No Need to Feel.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

The One Health Paradigm and Wild Animal Welfare Science.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

From Mollusks to Machines: An Ethical Framework Focused on the Urgency of Extreme Suffering.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
Same journal

Sentience and Why It Matters.

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees·2026
See all related articles

Related Experiment Video

Updated: May 27, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.3K

How do Persons With Dementia Suffer?

Jason Karlawish1

  • 1University of Pennsylvania, Philadelphia, PA, USA.

Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees
|February 20, 2025
PubMed
Summary
This summary is machine-generated.

Suffering in dementia patients is objectively observable by caregivers, not solely dependent on patient self-reports. Successful caregiving support fosters a sense of well-being, while its absence leads to suffering.

Keywords:
caregivingdementiamindsuffering

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.4K
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
06:52

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

9.6K

Related Experiment Videos

Last Updated: May 27, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.4K
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
06:52

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

9.6K

Area of Science:

  • Gerontology
  • Neuroscience
  • Philosophy of Mind

Background:

  • Dementia caregiving presents challenges in assessing patient well-being.
  • Patient self-reporting may not fully capture the experience of suffering in dementia.

Purpose of the Study:

  • To propose an objective framework for understanding suffering in persons with dementia.
  • To explore the role of caregiver observation in identifying dementia-related suffering.

Main Methods:

  • Philosophical argument and conceptual analysis.
  • Examination of the caregiver's role in perceiving and supporting the cognitive and emotional states of persons with dementia.

Main Results:

  • Suffering in dementia is knowable by others, independent of patient statements.
  • Caregiver observation is a key component in identifying suffering.
  • Successful mind-supportive caregiving creates a "feeling of being at home," reducing suffering.

Conclusions:

  • An objective account of suffering in dementia is possible through caregiver observation.
  • The quality of mind-supportive caregiving directly influences the presence or absence of suffering.
  • This perspective reframes suffering as an observable phenomenon in dementia care.